GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,466,000 | -23.9% | 260,000 | -38.8% | 0.02% | -38.2% |
| Q4 2017 | $15,075,000 | -38.1% | 425,000 | -29.2% | 0.03% | -42.4% |
| Q3 2017 | $24,360,000 | -33.5% | 600,000 | -29.4% | 0.06% | -34.4% |
| Q2 2017 | $36,652,000 | -27.6% | 850,000 | -29.2% | 0.09% | -29.7% |
| Q1 2017 | $50,592,000 | +64.2% | 1,200,000 | +50.0% | 0.13% | +52.4% |
| Q4 2016 | $30,808,000 | -10.7% | 800,000 | 0.0% | 0.08% | -11.6% |
| Q3 2016 | $34,504,000 | -0.5% | 800,000 | 0.0% | 0.10% | 0.0% |
| Q2 2016 | $34,672,000 | -2.3% | 800,000 | -8.6% | 0.10% | -1.0% |
| Q1 2016 | $35,481,000 | -21.8% | 875,000 | -22.2% | 0.10% | -19.3% |
| Q4 2015 | $45,394,000 | -9.2% | 1,125,000 | -13.5% | 0.12% | -14.4% |
| Q3 2015 | $49,985,000 | +207.8% | 1,300,000 | +300.0% | 0.14% | +178.0% |
| Q2 2013 | $16,240,000 | – | 325,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |